Annual report
4530.TEDINET S100THNM
Period2023-03-01 → 2024-02-29
Filed2024-05-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥141.7bn | 2023-03-01 → 2024-02-29 | Cons. | Net sales |
| Revenue | ¥128.3bn | 2022-03-01 → 2023-02-28 | Cons. | Net sales |
| Revenue | ¥120.2bn | 2021-03-01 → 2022-02-28d | Cons. | Net sales (5-year summary) |
| Revenue | ¥114.5bn | 2020-03-01 → 2021-02-28d | Cons. | Net sales (5-year summary) |
| Revenue | ¥141.0bn | 2019-03-01 → 2020-02-29d | Cons. | Net sales (5-year summary) |
| Operating income | ¥13.2bn | 2023-03-01 → 2024-02-29 | Cons. | Operating income |
| Operating income | ¥11.6bn | 2022-03-01 → 2023-02-28 | Cons. | Operating income |
| Ordinary income | ¥19.6bn | 2023-03-01 → 2024-02-29 | Cons. | Ordinary income |
| Ordinary income | ¥16.1bn | 2022-03-01 → 2023-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥12.6bn | 2021-03-01 → 2022-02-28d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥11.8bn | 2020-03-01 → 2021-02-28d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥25.6bn | 2019-03-01 → 2020-02-29d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥19.2bn | 2023-03-01 → 2024-02-29 | Cons. | Income before income taxes |
| Profit before tax | ¥16.1bn | 2022-03-01 → 2023-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥14.0bn | 2023-03-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥11.7bn | 2022-03-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥9.7bn | 2021-03-01 → 2022-02-28d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.3bn | 2020-03-01 → 2021-02-28d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥18.7bn | 2019-03-01 → 2020-02-29d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥14.4bn | 2023-03-01 → 2024-02-29 | Cons. | Profit loss |
| Net income | ¥12.1bn | 2022-03-01 → 2023-02-28 | Cons. | Profit loss |
| Total assets | ¥328.8bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥313.9bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥302.9bn | at 2022-02-28d | Cons. | Total assets (5-year summary) |
| Total assets | ¥299.9bn | at 2021-02-28d | Cons. | Total assets (5-year summary) |
| Total assets | ¥307.4bn | at 2020-02-29d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥61.7bn | at 2024-02-29 | Cons. | Liabilities |
| Total liabilities | ¥55.5bn | at 2023-02-28 | Cons. | Liabilities |
| Net assets / equity | ¥267.1bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥258.4bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥254.9bn | at 2022-02-28d | Cons. | Net assets |
| Net assets / equity | ¥253.8bn | at 2021-02-28d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥250.7bn | at 2020-02-29d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥112.5bn | at 2024-02-29 | Cons. | Cash and deposits |
| Cash and deposits | ¥122.2bn | at 2023-02-28 | Cons. | Cash and deposits |
| Cash & equivalents | ¥66.4bn | at 2024-02-29 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥65.4bn | at 2023-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥86.2bn | at 2022-02-28d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥91.4bn | at 2021-02-28d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥87.0bn | at 2020-02-29d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥18.2bn | 2023-03-01 → 2024-02-29 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥12.7bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥19.2bn | 2021-03-01 → 2022-02-28d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥5.3bn | 2020-03-01 → 2021-02-28d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥27.4bn | 2019-03-01 → 2020-02-29d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.5bn | 2023-03-01 → 2024-02-29 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥23.9bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥13.1bn | 2021-03-01 → 2022-02-28d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥7.8bn | 2020-03-01 → 2021-02-28d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥17.2bn | 2019-03-01 → 2020-02-29d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥16.7bn | 2023-03-01 → 2024-02-29 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥14.7bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥15.2bn | 2021-03-01 → 2022-02-28d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥7.2bn | 2020-03-01 → 2021-02-28d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥11.7bn | 2019-03-01 → 2020-02-29d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥181.62 | 2023-03-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥148.01 | 2022-03-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥118.92 | 2021-03-01 → 2022-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥113.22 | 2020-03-01 → 2021-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥227.58 | 2019-03-01 → 2020-02-29d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥181.42 | 2023-03-01 → 2024-02-29 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥147.88 | 2022-03-01 → 2023-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥118.84 | 2021-03-01 → 2022-02-28d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥113.11 | 2020-03-01 → 2021-02-28d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥227.3 | 2019-03-01 → 2020-02-29d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥3,492.62 | at 2024-02-29 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,294.2 | at 2023-02-28 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,171.83 | at 2022-02-28d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,083.98 | at 2021-02-28d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,046.45 | at 2020-02-29d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 80.5% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.6% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.5% | at 2022-02-28d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.1% | at 2021-02-28d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.9% | at 2020-02-29d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 5.4% | 2023-03-01 → 2024-02-29 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.7% | 2022-03-01 → 2023-02-28 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.8% | 2021-03-01 → 2022-02-28d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.7% | 2020-03-01 → 2021-02-28d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.5% | 2019-03-01 → 2020-02-29d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 2,759 | at 2024-02-29 | Cons. | Number of employees |
| Employees | 2,769 | at 2023-02-28 | Cons. | Number of employees |
| Employees | 2,784 | at 2022-02-28d | Cons. | Number of employees |
| Employees | 2,770 | at 2021-02-28d | Cons. | Number of employees |
| Employees | 2,745 | at 2020-02-29d | Cons. | Number of employees |
| Revenue | ¥96.6bn | 2023-03-01 → 2024-02-29 | Standalone | Net sales |
| Revenue | ¥93.0bn | 2022-03-01 → 2023-02-28 | Standalone | Net sales |
| Revenue | ¥90.6bn | 2021-03-01 → 2022-02-28d | Standalone | Net sales (5-year summary) |
| Revenue | ¥86.7bn | 2020-03-01 → 2021-02-28d | Standalone | Net sales (5-year summary) |
| Revenue | ¥109.8bn | 2019-03-01 → 2020-02-29d | Standalone | Net sales (5-year summary) |
| Operating income | ¥10.7bn | 2023-03-01 → 2024-02-29 | Standalone | Operating income |
| Operating income | ¥10.8bn | 2022-03-01 → 2023-02-28 | Standalone | Operating income |
| Ordinary income | ¥14.2bn | 2023-03-01 → 2024-02-29 | Standalone | Ordinary income |
| Ordinary income | ¥14.1bn | 2022-03-01 → 2023-02-28 | Standalone | Ordinary income |
| Ordinary income | ¥10.6bn | 2021-03-01 → 2022-02-28d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.4bn | 2020-03-01 → 2021-02-28d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥21.5bn | 2019-03-01 → 2020-02-29d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥13.8bn | 2023-03-01 → 2024-02-29 | Standalone | Income before income taxes |
| Profit before tax | ¥14.2bn | 2022-03-01 → 2023-02-28 | Standalone | Income before income taxes |
| Net income | ¥9.9bn | 2023-03-01 → 2024-02-29 | Standalone | Profit loss |
| Net income | ¥10.4bn | 2022-03-01 → 2023-02-28 | Standalone | Profit loss |
| Net income | ¥7.2bn | 2021-03-01 → 2022-02-28d | Standalone | Net income loss (5-year summary) |
| Net income | ¥8.3bn | 2020-03-01 → 2021-02-28d | Standalone | Net income loss (5-year summary) |
| Net income | ¥15.1bn | 2019-03-01 → 2020-02-29d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥256.0bn | at 2024-02-29 | Standalone | Assets |
| Total assets | ¥254.0bn | at 2023-02-28 | Standalone | Assets |
| Total assets | ¥254.3bn | at 2022-02-28d | Standalone | Total assets (5-year summary) |
| Total assets | ¥264.1bn | at 2021-02-28d | Standalone | Total assets (5-year summary) |
| Total assets | ¥266.1bn | at 2020-02-29d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥43.2bn | at 2024-02-29 | Standalone | Liabilities |
| Total liabilities | ¥39.5bn | at 2023-02-28 | Standalone | Liabilities |
| Net assets / equity | ¥212.8bn | at 2024-02-29 | Standalone | Net assets |
| Net assets / equity | ¥214.5bn | at 2023-02-28 | Standalone | Net assets |
| Net assets / equity | ¥222.4bn | at 2022-02-28d | Standalone | Net assets |
| Net assets / equity | ¥231.2bn | at 2021-02-28d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥225.6bn | at 2020-02-29d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥52.0bn | at 2024-02-29 | Standalone | Cash and deposits |
| Cash and deposits | ¥68.6bn | at 2023-02-28 | Standalone | Cash and deposits |
| EPS (basic) | ¥128.08 | 2023-03-01 → 2024-02-29 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥131.21 | 2022-03-01 → 2023-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥88.25 | 2021-03-01 → 2022-02-28d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥102.07 | 2020-03-01 → 2021-02-28d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥183.45 | 2019-03-01 → 2020-02-29d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥127.93 | 2023-03-01 → 2024-02-29 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥131.1 | 2022-03-01 → 2023-02-28 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥88.19 | 2021-03-01 → 2022-02-28d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥101.97 | 2020-03-01 → 2021-02-28d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥183.23 | 2019-03-01 → 2020-02-29d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥85 | 2023-03-01 → 2024-02-29 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥84.5 | 2022-03-01 → 2023-02-28 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥84 | 2021-03-01 → 2022-02-28d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥83.5 | 2020-03-01 → 2021-02-28d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥83 | 2019-03-01 → 2020-02-29d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,804.37 | at 2024-02-29 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,754.67 | at 2023-02-28 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,784.39 | at 2022-02-28d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,825.43 | at 2021-02-28d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,755.32 | at 2020-02-29d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 83.0% | at 2024-02-29 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.3% | at 2023-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.3% | at 2022-02-28d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.5% | at 2021-02-28d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.6% | at 2020-02-29d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 4.6% | 2023-03-01 → 2024-02-29 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.8% | 2022-03-01 → 2023-02-28 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.2% | 2021-03-01 → 2022-02-28d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.7% | 2020-03-01 → 2021-02-28d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.7% | 2019-03-01 → 2020-02-29d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 85,164,895 | at 2024-02-29 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 85,164,895 | at 2023-02-28 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 85,164,895 | at 2022-02-28d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 85,164,895 | at 2021-02-28d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 85,164,895 | at 2020-02-29d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,506 | at 2024-02-29 | Standalone | Number of employees |
| Employees | 1,521 | at 2023-02-28 | Standalone | Number of employees |
| Employees | 1,587 | at 2022-02-28d | Standalone | Number of employees |
| Employees | 1,583 | at 2021-02-28d | Standalone | Number of employees |
| Employees | 1,569 | at 2020-02-29d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 2
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2024-02-29 | 58 pure |
| Pharmaceutical Businessreportable segment | employees | at 2024-02-29 | 2701 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,978
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes significant events after reporting period consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of corporate bonds (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of borrowings (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of asset retirement obligations (text) | CurrentYearDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYearDuration | Text · Plus | |
| Balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Statement of income (text) | CurrentYearDuration | Text · Plus | |
| Detailed schedule of manufacturing cost (text) | CurrentYearDuration | Text · Plus | |
| Statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies financial statements (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates financial statements (text) | CurrentYearDuration | Text · Plus | |
| Monetary claims and obligations to subsidiaries and associates (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding amounts of reduction entry of property plant and equipment (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding transactions with affiliated entities (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes securities financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes tax effect accounting financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes business combinations financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes revenue recognition financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes significant events after reporting period financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of property plant and equipment etc (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of provisions (text) | CurrentYearDuration | Text · Plus | |
| Components of major assets and liabilities (text) | CurrentYearDuration | Text · Plus | |
| Other information financial statements etc (text) | CurrentYearDuration | Text · Plus | |
| Overview of operational procedures for shares (text) | FilingDateInstant | Text · Plus | |
| Information about parent company etc of reporting company (text) | FilingDateInstant | Text · Plus | |
| Other reference information (text) | FilingDateInstant | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |